Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass onweight loss at 5 years among patients with morbid obesity the SLEEVEPASS randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 319, Issue 3, 2018, Pages 241-254

  Salminen, Paulina ^a,b   Helmio, Mika ^a,b   Ovaska, Jari ^a,b   Juuti, Anne ^c   Leivonen, Marja ^c,d   Peromaa Haavisto, Pipsa ^e,f   Hurme, Saija ^b   Soinio, Minna ^a   Nuutila, Pirjo ^a,b   Victorzon, Mikael ^b,e  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

^f Tampere City Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE EVENT; ARTICLE; BODY MASS; BODY WEIGHT LOSS; CLINICAL EVALUATION; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LAPAROSCOPIC SLEEVE GASTRECTOMY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; ROUX-EN-Y GASTRIC BYPASS; SURGICAL MORTALITY; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; GASTRECTOMY; GASTRIC BYPASS SURGERY; HYPERLIPIDEMIA; LAPAROSCOPY; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC BYPASS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 85040993545     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.20313     Document Type: Article

References (37)

1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315 (21):2284-2291.
2. Puzziferri N, Roshek TB III, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: A systematic review. JAMA. 2014;312(9):934-942.
3. Helmio M, Victorzon M, Ovaska J, et al. SLEEVEPASS: A randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: Preliminary results. Surg Endosc. 2012;26(9):2521-2526.
4. Helmio M, Victorzon M, Ovaska J, et al. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up. Scand J Surg. 2014; 103(3):175-181.
5. Brethauer SA, Kim J, El Chaar M, et al; ASMBS Clinical Issues Committee. Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg. 2015;25(4):587-606.
6. Moorehead MK, Ardelt-Gattinger E, Lechner H, Oria HE. The validation of the Moorehead-Ardelt Quality of Life Questionnaire II. Obes Surg. 2003;13 (5):684-692.
7. Buse JB, Caprio S, CefaluWT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32 (11):2133-2135.
8. Catapano AL, Reiner Z, De Backer G, et al; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). ESC/EAS guidelines for the management of dyslipidaemias :the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3-46.
9. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc. 1991;37(3):383-393.
10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-213.
11. DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235(5):640-645.
12. Higa KD, Ho T, Boone KB. Laparoscopic Roux-en-Y gastric bypass: Technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A. 2001;11 (6):377-382.
13. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: Results after 1 and 3 years. Obes Surg. 2006;16(11):1450-1456.
14. Peterli R, Wolnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial. JAMA. doi:10.1001/jama.2017.20897
15. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: A prospective, double blind study. Ann Surg. 2008;247(3):401-407.
16. Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI <50 kg/m2. Obes Surg. 2011;21(11):1650-1656.
17. Schauer PR, Bhatt DL, Kirwan JP, et al; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes. N Engl J Med. 2017;376(7):641-651.
18. Zhang Y, Zhao H, Cao Z, et al. A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: A 5-year outcome. Obes Surg. 2014;24(10):1617-1624.
19. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3): 275-287.
20. Li J, Lai D, Wu D. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: A systematic review and meta-analysis. Obes Surg. 2016;26(2):429-442.
21. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: A randomized clinical trial. JAMA Surg. 2015;150 (10):931-940.
22. Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: Feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7): 716-726.
23. Ikramuddin S, Korner J, LeeWJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21): 2240-2249.
24. Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann Surg. 2017;265(3):466-473.
25. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013; 36(1):20-26.
26. Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311 (22):2297-2304.
27. Keidar A, Hershkop KJ, Marko L, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: A randomised trial. Diabetologia. 2013;56(9):1914-1918.
28. Lauffenburger JC, Shrank WH, Bitton A, et al. Association between patient-centered medical homes and adherence to chronic disease medications: A cohort study. Ann Intern Med. 2017; 166(2):81-88.
29. Arman GA, Himpens J, Dhaenens J, Ballet T, Vilallonga R, Leman G. Long-term (11+ years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778-1786.
30. DuPree CE, Blair K, Steele SR, Martin MJ. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: A national analysis. JAMA Surg. 2014;149(4):328-334.
31. Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett's esophagus after laparoscopic sleeve gastrectomy: Long-term follow-up. Obes Surg. 2017;27(12):3092-3101.
32. Oor JE, Roks DJ, Unlu C, Hazebroek EJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: A systematic review and meta-analysis. Am J Surg. 2016;211(1): 250-267.
33. Melissas J, Braghetto I, Molina JC, et al. Gastroesophageal reflux disease and sleeve gastrectomy. Obes Surg. 2015;25(12):2430-2435.
34. Stenberg E, Szabo E, Agren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass: A multicentre, randomised, parallel, open-label trial. Lancet. 2016;387(10026):1397-1404.
35. Stenberg E, Szabo E, Ottosson J, Naslund I. Outcomes of laparoscopic gastric bypass in a randomized clinical trial compared with a concurrent national database. Br J Surg. 2017;104 (5):562-569.
36. Brethauer SA, Aminian A, Romero-Talamas H, et al. Can diabetes be surgically cured? long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628-636.
37. Jimenez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256(6):1023-1029.